Related Experiment Video

Updated: Aug 8, 2026

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
18:01

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Published on: August 19, 2008

Oxotremorine acts as a partial nicotinic agonist on cultured chick myotubes

J Häggblad, H Eriksson, E Heilbronn

    Acta Pharmacologica Et Toxicologica
    |November 1, 1985
    PubMed

    Insights

    Oxotremorine inhibits nicotinic acetylcholine receptors in chick myotubes. This muscarinic agonist also induces ion flux, suggesting a partial agonist role in muscle function.

    Area of Science:

    • Neuroscience
    • Pharmacology

    Background:

    • Oxotremorine is a known muscarinic agonist.
    • Nicotinic acetylcholine receptors (nAChRs) are crucial for muscle function.
    • Understanding drug interactions with nAChRs is vital for therapeutic development.

    Purpose of the Study:

    • To investigate the effect of oxotremorine on chick myotube nicotinic acetylcholine receptors.
    • To characterize the ion flux induced by oxotremorine in myotubes.
    • To determine the mode of action of oxotremorine on these receptors.

    Main Methods:

    • Inhibition of 125I-alpha-bungarotoxin binding assays.
    • 86Rubidium (86Rb) ion flux measurements.
    • Comparative ion-flux studies using carbachol.

    Main Results:

    • Oxotremorine inhibited alpha-bungarotoxin binding to chick myotube nAChRs with an IC50 of 79 +/- 5 microM.
    • Oxotremorine induced a d-tubocurarine sensitive 86Rb influx with an EC50 of 50 +/- 15 microM.
    • Comparative studies indicated oxotremorine acts as a partial agonist.

    Conclusions:

    • Oxotremorine exhibits inhibitory effects on nicotinic acetylcholine receptors.
    • The compound modulates ion flux, consistent with partial agonism.
    • These findings contribute to understanding the complex pharmacology of oxotremorine and its interaction with cholinergic receptors.

    More Related Videos

    Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice07:09

    Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice

    Published on: September 8, 2011

    Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development07:56

    Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

    Published on: January 26, 2018

    Related Concept Videos

    Cholinergic Receptors: Nicotinic01:15

    Cholinergic Receptors: Nicotinic

    Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
    There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
    Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

    Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

    Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
    The direct-acting...
    Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

    Direct-Acting Cholinergic Agonists: Therapeutic Uses

    Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
    Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

    Indirect-Acting Cholinergic Agonists: Pharmacological Actions

    Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
    At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
    Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

    Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

    Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
    Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

    Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

    Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
    Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...